231 related articles for article (PubMed ID: 11071967)
1. Genetic analysis of nitric oxide and endothelin in end-stage renal disease.
Freedman BI; Yu H; Anderson PJ; Roh BH; Rich SS; Bowden DW
Nephrol Dial Transplant; 2000 Nov; 15(11):1794-800. PubMed ID: 11071967
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients.
Hirakawa S; Lange EM; Colicigno CJ; Freedman BI; Rich SS; Bowden DW
Am J Kidney Dis; 2003 Jul; 42(1):133-42. PubMed ID: 12830465
[TBL] [Abstract][Full Text] [Related]
3. Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease.
Yu H; Bowden DW; Spray BJ; Rich SS; Freedman BI
Hypertension; 1998 Apr; 31(4):906-11. PubMed ID: 9535413
[TBL] [Abstract][Full Text] [Related]
4. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans.
Freedman BI; Yu H; Spray BJ; Rich SS; Rothschild CB; Bowden DW
Kidney Int; 1997 Mar; 51(3):819-25. PubMed ID: 9067916
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 7p linkage and association study for diabetes related traits and type 2 diabetes in an African-American population enriched for nephropathy.
Leak TS; Langefeld CD; Keene KL; Gallagher CJ; Lu L; Mychaleckyj JC; Rich SS; Freedman BI; Bowden DW; Sale MM
BMC Med Genet; 2010 Feb; 11():22. PubMed ID: 20144192
[TBL] [Abstract][Full Text] [Related]
6. Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease.
Yu H; Anderson PJ; Freedman BI; Rich SS; Bowden DW
Genomics; 2000 Oct; 69(2):225-34. PubMed ID: 11031105
[TBL] [Abstract][Full Text] [Related]
7. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
El-Din Bessa SS; Hamdy SM
Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353
[TBL] [Abstract][Full Text] [Related]
8. Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus.
Lamnissou K; Zirogiannis P; Trygonis S; Demetriou K; Pierides A; Koptides M; Deltas CC
Genet Test; 2004; 8(3):319-24. PubMed ID: 15727257
[TBL] [Abstract][Full Text] [Related]
9. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy.
Keene KL; Mychaleckyj JC; Smith SG; Leak TS; Perlegas PS; Langefeld CD; Freedman BI; Rich SS; Bowden DW; Sale MM
Diabetes; 2008 Apr; 57(4):1057-62. PubMed ID: 18184924
[TBL] [Abstract][Full Text] [Related]
10. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus.
Freedman BI; Tuttle AB; Spray BJ
Am J Kidney Dis; 1995 May; 25(5):710-3. PubMed ID: 7747724
[TBL] [Abstract][Full Text] [Related]
11. A genome-wide association study for diabetic nephropathy genes in African Americans.
McDonough CW; Palmer ND; Hicks PJ; Roh BH; An SS; Cooke JN; Hester JM; Wing MR; Bostrom MA; Rudock ME; Lewis JP; Talbert ME; Blevins RA; Lu L; Ng MC; Sale MM; Divers J; Langefeld CD; Freedman BI; Bowden DW
Kidney Int; 2011 Mar; 79(5):563-72. PubMed ID: 21150874
[TBL] [Abstract][Full Text] [Related]
12. Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease.
Thaha M; Pranawa ; Yogiantoro M; Sutjipto ; Sunarjo ; Tanimoto M; Gohda T; Tomino Y
Clin Nephrol; 2008 Aug; 70(2):144-54. PubMed ID: 18793530
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with Type 2 diabetes.
Tiwari AK; Prasad P; B K T; Kumar KM; Ammini AC; Gupta A; Gupta R
J Diabetes Complications; 2009; 23(2):102-11. PubMed ID: 18413200
[TBL] [Abstract][Full Text] [Related]
14. Dinucleotide repeat polymorphisms in EDN1 and NOS3 are not associated with severe diabetic retinopathy in type 1 or type 2 diabetes.
Warpeha KM; Ah-Fat F; Harding S; Patterson CC; Xu W; Hart PM; Chakravarthy U; Hughes AE
Eye (Lond); 1999 Apr; 13 ( Pt 2)():174-8. PubMed ID: 10450377
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of markers on human chromosome 10, including the homologue of the rodent Rf-1 gene, for linkage to ESRD in black patients.
Yu H; Sale M; Rich SS; Spray BJ; Roh BH; Bowden DW; Freedman BI
Am J Kidney Dis; 1999 Feb; 33(2):294-300. PubMed ID: 10023641
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase gene polymorphisms and diabetic nephropathy.
Rippin JD; Patel A; Belyaev ND; Gill GV; Barnett AH; Bain SC
Diabetologia; 2003 Mar; 46(3):426-8. PubMed ID: 12687343
[TBL] [Abstract][Full Text] [Related]
17. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
[TBL] [Abstract][Full Text] [Related]
18. Association of eNOS Glu298Asp polymorphism with end-stage renal disease.
Noiri E; Satoh H; Taguchi J; Brodsky SV; Nakao A; Ogawa Y; Nishijima S; Yokomizo T; Tokunaga K; Fujita T
Hypertension; 2002 Oct; 40(4):535-40. PubMed ID: 12364359
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African-American and European-American populations.
Gallagher CJ; Keene KL; Mychaleckyj JC; Langefeld CD; Hirschhorn JN; Henderson BE; Gordon CJ; Freedman BI; Rich SS; Bowden DW; Sale MM
Diabetes; 2007 Mar; 56(3):675-84. PubMed ID: 17327435
[TBL] [Abstract][Full Text] [Related]
20. Association of ecNOS gene polymorphisms with end stage renal diseases.
Nagase S; Suzuki H; Wang Y; Kikuchi S; Hirayama A; Ueda A; Takada K; Oteki T; Obara M; Aoyagi K; Koyama A
Mol Cell Biochem; 2003 Feb; 244(1-2):113-8. PubMed ID: 12701818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
